TLR signaling controls lethal encephalitis in WNV-infected brain

Brain Research

Volumn 1574, Issue , 2014, Pages 84-95

  Sabouri, Amir H ^a,b   Marcondes, Maria Cecilia Garibaldi ^a   Flynn, Claudia ^a   Berger, Michael ^a,c   Xiao, Nengming ^a,d   Fox, Howard S ^a,e   Sarvetnick, Nora E ^a,f  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d San Diego Institute of Allergy and Immunology   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

MyD88; Toll like receptors (TLRs); Trif; West Nile virus

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; MEMBRANE PROTEIN; MYD88 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TLR3 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TLR7 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; CELL INFILTRATION; CELL SUSPENSION; CONTROLLED STUDY; FLAVIVIRUS INFECTION; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR MEMBRANE; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MALE; MICROGLIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS ENCEPHALITIS; VIRUS ENTRY; VIRUS EXPRESSION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION; WEST NILE VIRUS INFECTION; ANIMAL; BRAIN; C57BL MOUSE; CELL LINE; DISEASE COURSE; GENETICS; HAMSTER; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; SURVIVAL; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALIA; FLAVIVIRUS; MUS; SIMIAN IMMUNODEFICIENCY VIRUS; WEST NILE VIRUS;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BRAIN; CELL LINE; CRICETINAE; DISEASE PROGRESSION; MALE; MEMBRANE GLYCOPROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RNA, VIRAL; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84926208636     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.05.049     Document Type: Article

References (46)

1. Akira, S., Uematsu, S., Takeuchi, O., 2006. Pathogen recognition and innate immunity. Cell 124, 783-801.
2. Beasley, D.W., Li, L., Suderman, M.T., Barrett, A.D., 2002. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296, 17-23.
3. Beutler, B., 2009. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol. Rev. 227, 248-263.
4. Beverley, P.C., Merkenschlager, M., Terry, L., 1988. Phenotypic diversity of the CD45 antigen and its relationship to function. Immunology 1 (Suppl.), 3-5.
5. Beverley, P.C., 1991. CD45 isoform expression: implications for recirculation of naive and memory cells. Immunol. Res. 10, 196-198.
6. Cai, S., Batra, S., Shen, L., Wakamatsu, N., Jeyaseelan, S., 2009. Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J. Immunol. 183, 6629-6638.
7. Campbell, G.L., Marfin, A.A., Lanciotti, R.S., Gubler, D.J., 2002. West Nile virus. Lancet Infect. Dis. 2, 519-529.
8. Cartier, L., Hartley, O., Dubois-Dauphin, M., Krause, K.H., 2005. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48, 16-42.
9. Carty, M., Bowie, A.G., 2010. Recent insights into the role of Tolllike receptors in viral infection. Clin. Exp. Immunol. 161, 397-406.
10. Carty, M., Bowie, A.G., 2011. Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem. Pharmacol. 81, 825-837.
11. Cho, H., Proll, S.C., Szretter, K.J., Katze, M.G., Gale, M., Jr., 2013. Diamond, M.S., Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat. Med. 19, 458-464.
12. Cook, R.L., Xu, X., Yablonsky, E.J., Sakata, N., Tripp, J.H., Hess, R., Piazza, P., Rinaldo, C.R., Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am. J. Trop. Med. Hyg. 83, 1133-1136.
13. Daffis, S., Samuel, M.A., Suthar, M.S., Gale Jr., M., Diamond, M.S., 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82, 10349-10358.
14. Diamond, M.S., Roberts, T.G., Edgil, D., Lu, B., Ernst, J., Harris, E., 2000. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol. 74, 4957-4966.
15. Durrant, D.M., Robinette, M.L., Klein, R.S., 2013. IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J. Exp. Med. 210, 503-516.
16. Garcia-Tapia, D., Hassett, D.E., Mitchell Jr., W.J., Johnson, G.C., Kleiboeker, S.B., 2007. West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. J. Neurovirol. 13, 130-138.
17. Hanke, M.L., Kielian, T., 2011. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin. Sci. 121, 367-387.
18. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S., 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
19. Hill, W.G., 1998. Selection with recurrent backcrossing to develop congenic lines for quantitative trait loci analysis. Genetics 148, 1341-1352.
20. Hines, D.J., Choi, H.B., Hines, R.M., Phillips, A.G., MacVicar, B.A., 2013. Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PLoS One 8, e60388.
21. Hurlbut, H.S., Rizk, F., Taylor, R.M., Work, T.H., 1956. A study of the ecology of West Nile virus in Egypt. Am. J. Trop Med Hyg. 5, 579-620.
22. Janossy, G., Bofill, M., Rowe, D., Muir, J., Beverley, P.C., 1989. The tissue distribution of T lymphocytes expressing different CD45 polypeptides. Immunology 66, 517-525.
23. Kawai, T., Akira, S., 2006. Innate immune recognition of viral infection. Nat. Immunol. 7, 131-137.
24. Kong, K.F., Delroux, K., Wang, X., Qian, F., Arjona, A., Malawista, S.E., Fikrig, E., Montgomery, R.R., 2008. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol. 82, 7613-7623.
25. Marcondes, M.C., Spina, C., Bustamante, E., Fox, H., 2013. Increased toll-like receptor signaling pathways characterize CD8+ cells in rapidly progressive SIV infection. Biomed. Res. Int. 2013, 796014.
26. Murray, K., Baraniuk, S., Resnick, M., Arafat, R., Kilborn, C., Cain, K., Shallenberger, R., York, T.L., Martinez, D., Hellums, J.S., Hellums, D., Malkoff, M., Elgawley, N., McNeely, W., Khuwaja, S.A., Tesh, R. B., 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol. Infect. 134, 1325-1332.
27. O'Leary, D.R., Marfin, A.A., Montgomery, S.P., Kipp, A.M., Lehman, J.A., Biggerstaff, B.J., Elko, V.L., Collins, P.D., Jones, J.E., Campbell, G.L., 2004. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis. 4, 61-70.
28. O'Neill, L.A., Golenbock, D., Bowie, A.G., 2013. The history of Tolllike receptors - redefining innate immunity. Nat. Rev. Immunol. 13, 453-460.
29. Qureshi, S.T., Medzhitov, R., 2003. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun. 4, 87-94.
30. Samuel, M.A., Diamond, M.S., 2006. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80, 9349-9360.
31. Sellner, J., Dvorak, F., Zhou, Y., Haas, J., Kehm, R., Wildemann, B., Meyding-Lamade, U., 2005. Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci. Lett. 374, 197-202.
32. Shirato, K., Kimura, T., Mizutani, T., Kariwa, H., Takashima, I., 2004. Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J. Med. Virol. 74, 507-513.
33. Shirato, K., Miyoshi, H., Kariwa, H., Takashima, I., 2006. The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus. Virus Res. 121, 11-16.
34. Shrestha, B., Diamond, M.S., 2004. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78, 8312-8321.
35. Styer, L.M., Kent, K.A., Albright, R.G., Bennett, C.J., Kramer, L.D., Bernard, K.A., 2007. Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog. 3, 1262-1270.
36. Suthar, M.S., Brassil, M.M., Blahnik, G., McMillan, A., Ramos, H.J., Proll, S.C., Belisle, S.E., Katze, M.G., Gale Jr., M., 2013a. A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog. 9, e1003168.
37. Suthar, M.S., Diamond, M.S., Gale Jr., M., 2013b. West Nile virus infection and immunity. Nat Rev Microbiol. 11, 115-128.
38. Szretter, K.J., Daffis, S., Patel, J., Suthar, M.S., Klein, R.S., Gale, M., Jr., Diamond, M.S., The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J. Virol. 84, 12125-12138.
39. Tabeta, K., Georgel, P., Janssen, E., Du, X., Hoebe, K., Crozat, K., Mudd, S., Shamel, L., Sovath, S., Goode, J., Alexopoulou, L., Flavell, R.A., Beutler, B., 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101, 3516-3521.
40. Town, T., Bai, F., Wang, T., Kaplan, A.T., Qian, F., Montgomery, R.R., Anderson, J.F., Flavell, R.A., Fikrig, E., 2009. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 30, 242-253.
41. Wang, T., Town, T., Alexopoulou, L., Anderson, J.F., Fikrig, E., Flavell, R.A., 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10, 1366-1373.
42. Welte, T., Reagan, K., Fang, H., Machain-Williams, C., Zheng, X., Mendell, N., Chang, G.J., Wu, P., Blair, C.D., Wang, T., 2009. Tolllike receptor 7-induced immune response to cutaneous West Nile virus infection. J. Gen. Virol. 90, 2660-2668.
43. Wesche, H., Henzel, W.J., Shillinglaw, W., Li, S., Cao, Z., 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837-847.
44. Xie, G., Welte, T., Wang, J., Whiteman, M.C., Wicker, J.A., Saxena, V., Cong, Y., Barrett, A.D., Wang, T., 2013. A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways. Vaccine 31, 4143-4151.
45. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., Akira, S., 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672.
46. Yamamoto, M., Takeda, K., Akira, S., 2004. TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol. 40, 861-868.